| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgement to Reviewers 2011
|
|
|
2013
|
79 |
1 |
p. 97-99
3 p.
|
artikel
|
| 2 |
A phase II study of modulated-capecitabine and docetaxel in chemonaive patients with advanced non-small cell lung cancer (NSCLC)
|
Bertino, Erin M.
|
|
2013
|
79 |
1 |
p. 27-32
6 p.
|
artikel
|
| 3 |
Can we eliminate squamous cell carcinoma of the lung from testing of EML4-ALK fusion gene?
|
Ochi, Nobuaki
|
|
2013
|
79 |
1 |
p. 94-95
2 p.
|
artikel
|
| 4 |
Carboplatin dose calculation in lung cancer patients with low serum creatinine concentrations using CKD-EPI and Cockcroft–Gault with different weight descriptors
|
Kaag, Dieter
|
|
2013
|
79 |
1 |
p. 54-58
5 p.
|
artikel
|
| 5 |
Clinical factors predictive of long-term survival in advanced non-small cell lung cancer
|
Van Damme, V.
|
|
2013
|
79 |
1 |
p. 73-76
4 p.
|
artikel
|
| 6 |
Clinical impact of ki-67 labeling index in non-small cell lung cancer
|
Jakobsen, Jan Nyrop
|
|
2013
|
79 |
1 |
p. 1-7
7 p.
|
artikel
|
| 7 |
Clinical modes of EGFR tyrosine kinase inhibitor failure and subsequent management in advanced non-small cell lung cancer
|
Yang, Jin-Ji
|
|
2013
|
79 |
1 |
p. 33-39
7 p.
|
artikel
|
| 8 |
Contents
|
|
|
2013
|
79 |
1 |
p. vii-viii
nvt p.
|
artikel
|
| 9 |
Cutaneous lymphangitis carcinomatosa in a patient with lung adenocarcinoma: Case report and literature review
|
Prat, Lola
|
|
2013
|
79 |
1 |
p. 91-93
3 p.
|
artikel
|
| 10 |
Editorial Board
|
|
|
2013
|
79 |
1 |
p. v-
1 p.
|
artikel
|
| 11 |
Favorable clinical outcomes of pemetrexed treatment in anaplastic lymphoma kinase positive non-small-cell lung cancer
|
Lee, Ha Yeon
|
|
2013
|
79 |
1 |
p. 40-45
6 p.
|
artikel
|
| 12 |
Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose
|
Li, Hang
|
|
2013
|
79 |
1 |
p. 8-13
6 p.
|
artikel
|
| 13 |
Human papillomaviruses (HPVs) in lung cancer: A causative trigger or just a co-incidence?
|
Sourvinos, George
|
|
2013
|
79 |
1 |
p. 95-96
2 p.
|
artikel
|
| 14 |
IL-23 is pro-proliferative, epigenetically regulated and modulated by chemotherapy in non-small cell lung cancer
|
Baird, Anne-Marie
|
|
2013
|
79 |
1 |
p. 83-90
8 p.
|
artikel
|
| 15 |
Progression-free survival and overall survival in phase III trials of molecular-targeted agents in advanced non-small-cell lung cancer
|
Hotta, Katsuyuki
|
|
2013
|
79 |
1 |
p. 20-26
7 p.
|
artikel
|
| 16 |
Psf3 is a prognostic biomarker in lung adenocarcinoma
|
Hokka, Daisuke
|
|
2013
|
79 |
1 |
p. 77-82
6 p.
|
artikel
|
| 17 |
The A/G allele of eIF3a rs3740556 predicts platinum-based chemotherapy resistance in lung cancer patients
|
Xu, Xiaojing
|
|
2013
|
79 |
1 |
p. 65-72
8 p.
|
artikel
|
| 18 |
The influence of time of radio-chemotherapy and other therapeutic factors on treatment results in patients with limited disease small cell lung cancer
|
Sas-Korczynska, Beata
|
|
2013
|
79 |
1 |
p. 14-19
6 p.
|
artikel
|
| 19 |
Treatment of depression in people with lung cancer: A systematic review
|
Walker, Jane
|
|
2013
|
79 |
1 |
p. 46-53
8 p.
|
artikel
|
| 20 |
VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: Pooled analysis of SAKK19/05 and NTR528
|
Gautschi, Oliver
|
|
2013
|
79 |
1 |
p. 59-64
6 p.
|
artikel
|
Tijdschrift beschrijving